IL123053A - Detecting genetic predisposition to periodontal disease - Google Patents

Detecting genetic predisposition to periodontal disease

Info

Publication number
IL123053A
IL123053A IL12305398A IL12305398A IL123053A IL 123053 A IL123053 A IL 123053A IL 12305398 A IL12305398 A IL 12305398A IL 12305398 A IL12305398 A IL 12305398A IL 123053 A IL123053 A IL 123053A
Authority
IL
Israel
Prior art keywords
periodontal disease
genetic predisposition
detecting genetic
patient
genetic polymorphism
Prior art date
Application number
IL12305398A
Other languages
English (en)
Other versions
IL123053A0 (en
Original Assignee
Medical Science Sys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Science Sys Inc filed Critical Medical Science Sys Inc
Publication of IL123053A0 publication Critical patent/IL123053A0/xx
Publication of IL123053A publication Critical patent/IL123053A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12305398A 1995-08-03 1998-10-26 Detecting genetic predisposition to periodontal disease IL123053A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/510,696 US5686246A (en) 1995-08-03 1995-08-03 Detecting genetic predisposition to periodontal disease

Publications (2)

Publication Number Publication Date
IL123053A0 IL123053A0 (en) 1998-12-06
IL123053A true IL123053A (en) 2000-01-31

Family

ID=24031795

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12305398A IL123053A (en) 1995-08-03 1998-10-26 Detecting genetic predisposition to periodontal disease

Country Status (25)

Country Link
US (1) US5686246A (xx)
EP (2) EP0853630A4 (xx)
JP (1) JP4042811B2 (xx)
KR (1) KR19990036067A (xx)
CN (1) CN1198166A (xx)
AR (1) AR003182A1 (xx)
AT (1) ATE207927T1 (xx)
AU (1) AU719965B2 (xx)
BR (1) BR9604044A (xx)
CA (1) CA2228424C (xx)
DE (1) DE69616478T2 (xx)
DK (1) DK0769560T3 (xx)
ES (1) ES2166866T3 (xx)
ID (1) ID17246A (xx)
IL (1) IL123053A (xx)
IS (1) IS4653A (xx)
MX (1) MX9800941A (xx)
MY (1) MY132156A (xx)
NO (1) NO980439L (xx)
NZ (1) NZ315836A (xx)
PT (1) PT769560E (xx)
SI (1) SI9620098A (xx)
TW (1) TW406130B (xx)
WO (1) WO1997006180A1 (xx)
ZA (1) ZA966585B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951721B2 (en) * 1996-02-12 2005-10-04 Gene Logic Inc. Method for determining the haplotype of a human BRCA1 gene
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US7820383B2 (en) * 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction
US6210877B1 (en) 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
US6524795B1 (en) 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
AU760856B2 (en) * 1997-05-29 2003-05-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for chronic obstructive airway disease
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
GB9723553D0 (en) * 1997-11-07 1998-01-07 Duff Gordon W Prediction of the risk of chronic obstructive airway disease
US20050282198A1 (en) * 1997-05-29 2005-12-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
AU9217198A (en) * 1997-09-03 1999-03-22 Oncormed Method for predicting prognosis and treatment response for genetically based abnormalities
US6746839B1 (en) 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
US6130042A (en) * 1998-03-05 2000-10-10 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for diagnosing periodontal disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
IL139131A0 (en) * 1998-04-21 2001-11-25 Interleukin Genetics Inc Fetal testing for prediction of low birth weight
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
US6225069B1 (en) * 2000-02-29 2001-05-01 The Board Of Trustees Of The University Of Arkansas Methods to identify genetic predisposition to alzheimer's disease
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
DE10112348A1 (de) * 2001-03-13 2002-10-02 Antje Roetger Nukleotidträger zur Diagnose und Therapie oraler Erkrankungen
KR20040026665A (ko) * 2001-06-15 2004-03-31 인터레우킨 제네틱스, 인코포레이티드 노화 관련 증상의 조기 개시를 검출 및 치료하는 방법
US20080311581A1 (en) * 2001-11-19 2008-12-18 David Wyllie Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
WO2003044176A2 (en) * 2001-11-19 2003-05-30 Interleukin Genetics, Inc. Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US20030148288A1 (en) * 2002-02-01 2003-08-07 Yi-Wei Tang Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
US20040229228A1 (en) * 2002-07-25 2004-11-18 Northwestern University Il-1 genotype in early kidney allograft rejection
ATE389034T1 (de) 2002-09-30 2008-03-15 Novartis Pharma Gmbh Verfahren zur voraussage der erhöhung von cholesterin während einer immunosuppresiven therapie
CA2534365A1 (en) * 2003-08-08 2005-02-17 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis
US20070003947A1 (en) * 2005-01-18 2007-01-04 Decarlo Arthur A Detecting genetic risk for periodontal disease
EP1851245B1 (en) 2005-01-26 2012-10-10 Amgen Fremont Inc. Antibodies against interleukin-1 beta
US8105775B2 (en) * 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CA2668722A1 (en) * 2006-11-15 2008-05-22 Interleukin Genetics, Inc. The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
US7925192B2 (en) * 2007-09-04 2011-04-12 Ricoh Company, Ltd. Developing roller, developing device, process cartridge, and image forming apparatus
CA2705142A1 (en) * 2007-11-08 2009-05-14 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
JP5762282B2 (ja) 2008-05-02 2015-08-12 インタールーキン ジェネティクス， インコーポレイテッド 変形性関節症に関連する状態に対する遺伝的素因の検出
WO2009135219A2 (en) * 2008-05-02 2009-11-05 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
BR112013014479B1 (pt) 2010-12-09 2020-10-27 Orig3N, Inc. métodos para determinar a gravidade e progressão de doença periodontal
AU2017207341A1 (en) 2016-01-12 2018-08-02 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
KR101894018B1 (ko) * 2017-02-09 2018-08-31 주식회사 테라젠이텍스 치주 질환의 위험도를 예측하기 위한 조성물, 마이크로어레이, 및 키트, 및 이를 이용한 방법
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110920A (en) * 1982-01-22 1992-05-05 Cetus Corporation HLA typing method and DNA probes used therein
US4582788A (en) * 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
US4666828A (en) * 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
US5268267A (en) * 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
US5158871A (en) * 1988-02-12 1992-10-27 University Of Connecticut Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5328829A (en) * 1990-07-05 1994-07-12 Forsyth Dental Infirmary For Children Method of determining sites of active periodontal disease

Also Published As

Publication number Publication date
JP4042811B2 (ja) 2008-02-06
TW406130B (en) 2000-09-21
KR19990036067A (ko) 1999-05-25
EP0769560A2 (en) 1997-04-23
CA2228424C (en) 2005-12-27
DE69616478T2 (de) 2002-08-08
CA2228424A1 (en) 1997-02-20
NO980439L (no) 1998-03-13
EP0769560A3 (en) 1999-11-24
AR003182A1 (es) 1998-07-08
EP0853630A4 (en) 1999-10-27
AU6763396A (en) 1997-03-05
DE69616478D1 (de) 2001-12-06
ID17246A (id) 1997-12-11
IL123053A0 (en) 1998-12-06
NO980439D0 (no) 1998-02-02
DK0769560T3 (da) 2002-02-18
MX9800941A (es) 1998-10-31
IS4653A (is) 1998-01-19
JP2001517067A (ja) 2001-10-02
PT769560E (pt) 2002-04-29
SI9620098A (sl) 1998-10-31
ZA966585B (en) 1997-02-26
NZ315836A (en) 1999-10-28
ES2166866T3 (es) 2002-05-01
ATE207927T1 (de) 2001-11-15
US5686246A (en) 1997-11-11
BR9604044A (pt) 1998-06-09
AU719965B2 (en) 2000-05-18
EP0769560B1 (en) 2001-10-31
CN1198166A (zh) 1998-11-04
EP0853630A1 (en) 1998-07-22
WO1997006180A1 (en) 1997-02-20
MY132156A (en) 2007-09-28

Similar Documents

Publication Publication Date Title
IL123053A (en) Detecting genetic predisposition to periodontal disease
CA2226223A1 (en) Detecting genetic predisposition for osteoporosis
FR2755149B1 (fr) Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
CA2267155A1 (en) Detecting genetic predisposition to sight-threatening diabetic retinopathy
IL124185A (en) Method and apparatus for identifying classifying or quantifying DNA sequences in a sample without sequencing
EP0530009A3 (en) Method of characterising genomic dna
GR3030430T3 (en) Method and apparatus for fabricating microarrays of biological samples
FR2694754B1 (fr) Fragments d'ADN de mycobactéries, amorces d'amplification, sondes d'hybridation, réactifs et procédé de détection de détection de mycobactéries.
IL72499A (en) Kit and method for the detection of bacteria in a biological test sample by nucleic acid hybridization
NZ284412A (en) Apolipoprotein E polymorphism and treatment of Alzheimer's Disease
WO2000037679A3 (en) Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis
WO1999029903A3 (en) Cancer susceptibility mutations of brca1
EP0398709A3 (en) Genetic diagnosis of torsion dystonia
DE69120526D1 (de) Allelische verbindung des humanen dopamin-(d2)rezeptor-gens in kompulsionsstörungen wie alkoholismus
EP0382261A3 (en) Dna probes to vntr loci
ES2082881T3 (es) Procedimiento para la deteccion y determinacion cuantitativa de cepas de nitrosomonas en aguas residuales o suelos.
FR2603047B1 (fr) Sonde d'hybridation pour la detection de sequences nucleotidiques polymorphes contenues dans un echantillon d'adn humain ou animal, procede de detection de sequences d'adn polymorphes utilisant une telle sonde, ses applications biologiques
FR2733754B1 (fr) Fragment de l'adn genomique de clavibacter michiganensis, sonde d'hybridation, amorce d'amplification, reactif et procede de detection de clavibacter michiganensis
FR2668162B1 (fr) Fragments d'adn, procede et coffret de diagnostic pour la detection des porteurs de la mutation delta-f-508 responsable de la mucoviscidose.
WO2002090585A3 (en) Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
FR2721405B1 (fr) Méthode d'analyse pour déterminer la capacité de fécondation d'un échantillon de sperme humain et kit correspondant.
WO1999032643A3 (en) Mood disorder gene
FR2703153B1 (fr) Spectrophotocolorimetre pour l'analyse spectrophotocolorimetrique d'un echantillon et procede de mesure spectrophotocolorimetrique.
ATE266736T1 (de) Verfahren zum nachweis und zur bestimmung enzymatischer reaktionen in urin
FI921046A (fi) Maidon soluluvun määrittäminen spesifisillä nukleiinihappokoettimilla

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees